Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dengue Virus-1
- Development stage
- Unknown
- Lead developer
- United States Army
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intratumoral Injection, Inoculated In The Deltoid Region
01
Overview
Dengue Virus-1 is one of the four serotypes of the dengue virus, a mosquito-borne flavivirus. Specific attenuated strains, such as #45AZ5 (also known as PV-001-DV), are being investigated for their therapeutic potential as oncolytic viruses in advanced melanoma, where they aim to stimulate the immune system. This strain was originally developed by the US Army as a potential preventative vaccine for dengue fever. Dengue Virus-1 is also utilized as a live virus human challenge strain (DENV-1-LVHC strain 45AZ5) in clinical trials to evaluate vaccine efficacy and study dengue pathogenesis. The virus naturally infects humans and *Aedes aegypti* mosquitoes, and its NS5 protein has been implicated in immune evasion.
- Other names
- DENV-1DENV1DENV 1
Beyond the preview
Go deeper on Dengue Virus-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dengue Virus-1.